The Serum Institute of India is the first Indian company to seek approval for the COVID-19 booster dose.
Officials said Poonawala's narco test was completely successful and his health condition was absolutely fine.
The CoWIN portal will be made available in Hindi and 14 regional languages by next week, while 17 more laboratories will be added to the INSACOG network to monitor the variants of COVID-19, the health ministry said on Monday.
According to officials, an additional dose of vaccine is different from a booster dose.
A key lesson for the pharmaceutical sector in this case is to not downplay the significant impact that regulatory non-compliance can have on operations.
If the company manages to get a go-ahead from the regulator for this plant, it might result in resumption of supplies of several of their products, barred from the US last year.
Why did the department and his colleagues not stop this 'rogue' officer from implicating an innocent man while the entire nation was watching for weeks? The answer is they either approved, or disapproved and refused to intervene or they didn't care, notes Aakar Patel.
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.
Goa on Sunday joined several other states in banning the sale of Nestle's instant noodle brand 'Maggi' which is at the centre of a raging nationwide row over food safety concerns.
These self-appointed well-wishers of AMU are basically for the control or police model of university governance. They have no faith whatsoever in the democratic functioning of the universities, observes Faizan Mustafa, former dean, Faculty of Law, and Registrar, Aligarh Muslim University.
Some Indian generic drugmakers are, however, uncertain about the pace of approvals in the near future.
Credit Suisse analysts cut their rating on Sun Pharma stock to 'neutral' from 'outperform
Slapped with Rs 242-crore fine by US authorities for rule violations at Toansa unit, say sources; 2nd such hefty rap in the recent past from US regulators for bending rules.
The state government had in the first week of June banned Maggi sale in the state after the product failed the food safety test.
Informing about his decision, Maurya said in a tweet in Hindi, 'Due to the attitude of gross neglect towards Dalits, backwards, farmers, unemployed youth and small and medium-sized traders, I am resigning from the council of ministers of Yogi (Adityanath) of UP.'
The rap from both the US and UK drug regulators, including the latest one from the latter, has hit the scrip.
"Due to scheduling reasons, it is inconvenient for China to attend the meeting," Chinese Foreign Ministry spokesman Wang Wenbin told mediapersons.
'There are no drugs to be given in the first week, if you have been hospitalised.' 'If you're getting any drug, that drug is likely to be unnecessary.' 'Or the hospitalisation is unnecessary.'
Such is the situation of the government in Punjab, the prime minister said while hitting out the Congress, and asserted that he will come to Jalandhar again and pay obeisance at the Devi Talab Mandir.
The government plans to rationalise trade margins for many other medical devices, besides stents and knee implants.
Analysts are eyeing bigger launches that will positively impact company's fortunes.
Low growth visibility and trouble with regulators have resulted in lack of interest from investors
The names of two Indian-Americans -- Seema Verma and Bobby Jindal -- have emerged as possible candidates.
The BSE Midcap also cut all its intraday gains to shed 0.3% at close
The merger has fortified Sun Pharma's position.
Since 2013, the FDA has banned around 30 Indian drug manufacturing units for various violations
As the COVID-19 vaccination of children falling into the age bracket of 15 to 18 years is scheduled to begin from January 3, the Kerala health department has prepared an action plan for inoculation of all eligible beneficiaries.
Maharashtra Chief Minister Devendra Fadnavis on Saturday allocated portfolios to the twenty-member council of ministers, including 10 of the Shiv Sena, who were inducted into his expanded cabinet.
The Subject Expert Committee on COVID-19 of the CDSCO on October 12 after deliberating Bharat Biotech's EUA application had recommended granting emergency use approval to Covaxin for use in the 12-18 years age group with certain conditions.
Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.
Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.
The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it
With this allocation of portfolios, the Sharad Pawar-led NCP has got most of the 'plum' ministries.
On her maiden visit to India, US Food and Drug Administrator Margaret A Hamburg has said recent lapses in quality by a handful of pharma companies has overshadowed the good things done by other Indian companies, who emphasise on quality products and practices.
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.
Paul noted that "three to four months from now, there will be other vaccines and the stockpile will be even bigger. "And more acceleration can be brought about in the vaccination programme," Paul added.
The court had provided a conditional relief to Nestle India.
'Nobody is attacking the company or the vaccine.' 'The concerns are about the process and the lack of transparency.'
Vice President Mike Pence said Trump had authorised a ban on entry of foreign nationals who travelled to Iran in the last 14 days. The United States also advised its citizens not to travel to parts of South Korea and Italy, from where reports of coronavirus have appeared.
The news that exports to the US will not restart before next year as well as the September quarter performance are sentiment dampeners.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances